Global Intramuscular HPV Vaccine Supply, Demand and Key Producers, 2023-2029
The global Intramuscular HPV Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
The characteristics and precautions of intramuscular injection of HPV vaccine include: recommended age, vaccine dose and vaccination schedule, vaccination site, safety and side effects, catch-up and vaccination recommendations.
The intramuscular HPV vaccine is a vaccine to prevent human papillomavirus infection. It boosts the body's immunity against papillomaviruses by injecting the vaccine into muscle tissue, which triggers an immune response.
This report studies the global Intramuscular HPV Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Intramuscular HPV Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intramuscular HPV Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Intramuscular HPV Vaccine total production and demand, 2018-2029, (Units)
Global Intramuscular HPV Vaccine total production value, 2018-2029, (USD Million)
Global Intramuscular HPV Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Intramuscular HPV Vaccine consumption by region & country, CAGR, 2018-2029 & (Units)
U.S. VS China: Intramuscular HPV Vaccine domestic production, consumption, key domestic manufacturers and share
Global Intramuscular HPV Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Units)
Global Intramuscular HPV Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Intramuscular HPV Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (Units).
This reports profiles key players in the global Intramuscular HPV Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Sharp & Dohme (MSD), Pfizer, Sanofi, GSK, Serum Institute, Astellas Pharma, CSL, Emergent BioSolutions and GlaxoSmithKline, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intramuscular HPV Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Intramuscular HPV Vaccine Market, By Region:
1. How big is the global Intramuscular HPV Vaccine market?
2. What is the demand of the global Intramuscular HPV Vaccine market?
3. What is the year over year growth of the global Intramuscular HPV Vaccine market?
4. What is the production and production value of the global Intramuscular HPV Vaccine market?
5. Who are the key producers in the global Intramuscular HPV Vaccine market?
6. What are the growth factors driving the market demand?
The characteristics and precautions of intramuscular injection of HPV vaccine include: recommended age, vaccine dose and vaccination schedule, vaccination site, safety and side effects, catch-up and vaccination recommendations.
The intramuscular HPV vaccine is a vaccine to prevent human papillomavirus infection. It boosts the body's immunity against papillomaviruses by injecting the vaccine into muscle tissue, which triggers an immune response.
This report studies the global Intramuscular HPV Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Intramuscular HPV Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Intramuscular HPV Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Intramuscular HPV Vaccine total production and demand, 2018-2029, (Units)
Global Intramuscular HPV Vaccine total production value, 2018-2029, (USD Million)
Global Intramuscular HPV Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Intramuscular HPV Vaccine consumption by region & country, CAGR, 2018-2029 & (Units)
U.S. VS China: Intramuscular HPV Vaccine domestic production, consumption, key domestic manufacturers and share
Global Intramuscular HPV Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (Units)
Global Intramuscular HPV Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (Units)
Global Intramuscular HPV Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (Units).
This reports profiles key players in the global Intramuscular HPV Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Sharp & Dohme (MSD), Pfizer, Sanofi, GSK, Serum Institute, Astellas Pharma, CSL, Emergent BioSolutions and GlaxoSmithKline, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Intramuscular HPV Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Intramuscular HPV Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Bivalent
- Quadrivalent
- Nine-valent
- Male
- Female
- Merck Sharp & Dohme (MSD)
- Pfizer
- Sanofi
- GSK
- Serum Institute
- Astellas Pharma
- CSL
- Emergent BioSolutions
- GlaxoSmithKline
- Johnson & Johnson
- MedImmune
- Walvax Biotechnology
- Liaoning Chengda Biotechnology
- Hualan Biological Engineering
- Sinovac Biotech
- Chongqing Zhifei Biological Products
- Chang Chun High and New Technology Industries (Group)
- Beijing Wantai Biological Pharmacy Enterprise
- Jiangsu Recbio Technology
1. How big is the global Intramuscular HPV Vaccine market?
2. What is the demand of the global Intramuscular HPV Vaccine market?
3. What is the year over year growth of the global Intramuscular HPV Vaccine market?
4. What is the production and production value of the global Intramuscular HPV Vaccine market?
5. Who are the key producers in the global Intramuscular HPV Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Intramuscular HPV Vaccine Introduction
1.2 World Intramuscular HPV Vaccine Supply & Forecast
1.2.1 World Intramuscular HPV Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Intramuscular HPV Vaccine Production (2018-2029)
1.2.3 World Intramuscular HPV Vaccine Pricing Trends (2018-2029)
1.3 World Intramuscular HPV Vaccine Production by Region (Based on Production Site)
1.3.1 World Intramuscular HPV Vaccine Production Value by Region (2018-2029)
1.3.2 World Intramuscular HPV Vaccine Production by Region (2018-2029)
1.3.3 World Intramuscular HPV Vaccine Average Price by Region (2018-2029)
1.3.4 North America Intramuscular HPV Vaccine Production (2018-2029)
1.3.5 Europe Intramuscular HPV Vaccine Production (2018-2029)
1.3.6 China Intramuscular HPV Vaccine Production (2018-2029)
1.3.7 Japan Intramuscular HPV Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intramuscular HPV Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intramuscular HPV Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Intramuscular HPV Vaccine Demand (2018-2029)
2.2 World Intramuscular HPV Vaccine Consumption by Region
2.2.1 World Intramuscular HPV Vaccine Consumption by Region (2018-2023)
2.2.2 World Intramuscular HPV Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Intramuscular HPV Vaccine Consumption (2018-2029)
2.4 China Intramuscular HPV Vaccine Consumption (2018-2029)
2.5 Europe Intramuscular HPV Vaccine Consumption (2018-2029)
2.6 Japan Intramuscular HPV Vaccine Consumption (2018-2029)
2.7 South Korea Intramuscular HPV Vaccine Consumption (2018-2029)
2.8 ASEAN Intramuscular HPV Vaccine Consumption (2018-2029)
2.9 India Intramuscular HPV Vaccine Consumption (2018-2029)
3 WORLD INTRAMUSCULAR HPV VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Intramuscular HPV Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Intramuscular HPV Vaccine Production by Manufacturer (2018-2023)
3.3 World Intramuscular HPV Vaccine Average Price by Manufacturer (2018-2023)
3.4 Intramuscular HPV Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Intramuscular HPV Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Intramuscular HPV Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Intramuscular HPV Vaccine in 2022
3.6 Intramuscular HPV Vaccine Market: Overall Company Footprint Analysis
3.6.1 Intramuscular HPV Vaccine Market: Region Footprint
3.6.2 Intramuscular HPV Vaccine Market: Company Product Type Footprint
3.6.3 Intramuscular HPV Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Intramuscular HPV Vaccine Production Value Comparison
4.1.1 United States VS China: Intramuscular HPV Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Intramuscular HPV Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Intramuscular HPV Vaccine Production Comparison
4.2.1 United States VS China: Intramuscular HPV Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Intramuscular HPV Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Intramuscular HPV Vaccine Consumption Comparison
4.3.1 United States VS China: Intramuscular HPV Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Intramuscular HPV Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Intramuscular HPV Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Intramuscular HPV Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Intramuscular HPV Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Intramuscular HPV Vaccine Production (2018-2023)
4.5 China Based Intramuscular HPV Vaccine Manufacturers and Market Share
4.5.1 China Based Intramuscular HPV Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Intramuscular HPV Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Intramuscular HPV Vaccine Production (2018-2023)
4.6 Rest of World Based Intramuscular HPV Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Intramuscular HPV Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Intramuscular HPV Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Intramuscular HPV Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Intramuscular HPV Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Bivalent
5.2.2 Quadrivalent
5.2.3 Nine-valent
5.3 Market Segment by Type
5.3.1 World Intramuscular HPV Vaccine Production by Type (2018-2029)
5.3.2 World Intramuscular HPV Vaccine Production Value by Type (2018-2029)
5.3.3 World Intramuscular HPV Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Intramuscular HPV Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Male
6.2.2 Female
6.3 Market Segment by Application
6.3.1 World Intramuscular HPV Vaccine Production by Application (2018-2029)
6.3.2 World Intramuscular HPV Vaccine Production Value by Application (2018-2029)
6.3.3 World Intramuscular HPV Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck Sharp & Dohme (MSD)
7.1.1 Merck Sharp & Dohme (MSD) Details
7.1.2 Merck Sharp & Dohme (MSD) Major Business
7.1.3 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Product and Services
7.1.4 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Sharp & Dohme (MSD) Recent Developments/Updates
7.1.6 Merck Sharp & Dohme (MSD) Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Intramuscular HPV Vaccine Product and Services
7.2.4 Pfizer Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Sanofi
7.3.1 Sanofi Details
7.3.2 Sanofi Major Business
7.3.3 Sanofi Intramuscular HPV Vaccine Product and Services
7.3.4 Sanofi Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Sanofi Recent Developments/Updates
7.3.6 Sanofi Competitive Strengths & Weaknesses
7.4 GSK
7.4.1 GSK Details
7.4.2 GSK Major Business
7.4.3 GSK Intramuscular HPV Vaccine Product and Services
7.4.4 GSK Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 GSK Recent Developments/Updates
7.4.6 GSK Competitive Strengths & Weaknesses
7.5 Serum Institute
7.5.1 Serum Institute Details
7.5.2 Serum Institute Major Business
7.5.3 Serum Institute Intramuscular HPV Vaccine Product and Services
7.5.4 Serum Institute Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Serum Institute Recent Developments/Updates
7.5.6 Serum Institute Competitive Strengths & Weaknesses
7.6 Astellas Pharma
7.6.1 Astellas Pharma Details
7.6.2 Astellas Pharma Major Business
7.6.3 Astellas Pharma Intramuscular HPV Vaccine Product and Services
7.6.4 Astellas Pharma Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Astellas Pharma Recent Developments/Updates
7.6.6 Astellas Pharma Competitive Strengths & Weaknesses
7.7 CSL
7.7.1 CSL Details
7.7.2 CSL Major Business
7.7.3 CSL Intramuscular HPV Vaccine Product and Services
7.7.4 CSL Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 CSL Recent Developments/Updates
7.7.6 CSL Competitive Strengths & Weaknesses
7.8 Emergent BioSolutions
7.8.1 Emergent BioSolutions Details
7.8.2 Emergent BioSolutions Major Business
7.8.3 Emergent BioSolutions Intramuscular HPV Vaccine Product and Services
7.8.4 Emergent BioSolutions Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Emergent BioSolutions Recent Developments/Updates
7.8.6 Emergent BioSolutions Competitive Strengths & Weaknesses
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Details
7.9.2 GlaxoSmithKline Major Business
7.9.3 GlaxoSmithKline Intramuscular HPV Vaccine Product and Services
7.9.4 GlaxoSmithKline Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 GlaxoSmithKline Recent Developments/Updates
7.9.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Details
7.10.2 Johnson & Johnson Major Business
7.10.3 Johnson & Johnson Intramuscular HPV Vaccine Product and Services
7.10.4 Johnson & Johnson Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Johnson & Johnson Recent Developments/Updates
7.10.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.11 MedImmune
7.11.1 MedImmune Details
7.11.2 MedImmune Major Business
7.11.3 MedImmune Intramuscular HPV Vaccine Product and Services
7.11.4 MedImmune Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 MedImmune Recent Developments/Updates
7.11.6 MedImmune Competitive Strengths & Weaknesses
7.12 Walvax Biotechnology
7.12.1 Walvax Biotechnology Details
7.12.2 Walvax Biotechnology Major Business
7.12.3 Walvax Biotechnology Intramuscular HPV Vaccine Product and Services
7.12.4 Walvax Biotechnology Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Walvax Biotechnology Recent Developments/Updates
7.12.6 Walvax Biotechnology Competitive Strengths & Weaknesses
7.13 Liaoning Chengda Biotechnology
7.13.1 Liaoning Chengda Biotechnology Details
7.13.2 Liaoning Chengda Biotechnology Major Business
7.13.3 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Product and Services
7.13.4 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Liaoning Chengda Biotechnology Recent Developments/Updates
7.13.6 Liaoning Chengda Biotechnology Competitive Strengths & Weaknesses
7.14 Hualan Biological Engineering
7.14.1 Hualan Biological Engineering Details
7.14.2 Hualan Biological Engineering Major Business
7.14.3 Hualan Biological Engineering Intramuscular HPV Vaccine Product and Services
7.14.4 Hualan Biological Engineering Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Hualan Biological Engineering Recent Developments/Updates
7.14.6 Hualan Biological Engineering Competitive Strengths & Weaknesses
7.15 Sinovac Biotech
7.15.1 Sinovac Biotech Details
7.15.2 Sinovac Biotech Major Business
7.15.3 Sinovac Biotech Intramuscular HPV Vaccine Product and Services
7.15.4 Sinovac Biotech Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Sinovac Biotech Recent Developments/Updates
7.15.6 Sinovac Biotech Competitive Strengths & Weaknesses
7.16 Chongqing Zhifei Biological Products
7.16.1 Chongqing Zhifei Biological Products Details
7.16.2 Chongqing Zhifei Biological Products Major Business
7.16.3 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Product and Services
7.16.4 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Chongqing Zhifei Biological Products Recent Developments/Updates
7.16.6 Chongqing Zhifei Biological Products Competitive Strengths & Weaknesses
7.17 Chang Chun High and New Technology Industries (Group)
7.17.1 Chang Chun High and New Technology Industries (Group) Details
7.17.2 Chang Chun High and New Technology Industries (Group) Major Business
7.17.3 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Product and Services
7.17.4 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Chang Chun High and New Technology Industries (Group) Recent Developments/Updates
7.17.6 Chang Chun High and New Technology Industries (Group) Competitive Strengths & Weaknesses
7.18 Beijing Wantai Biological Pharmacy Enterprise
7.18.1 Beijing Wantai Biological Pharmacy Enterprise Details
7.18.2 Beijing Wantai Biological Pharmacy Enterprise Major Business
7.18.3 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Product and Services
7.18.4 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
7.18.6 Beijing Wantai Biological Pharmacy Enterprise Competitive Strengths & Weaknesses
7.19 Jiangsu Recbio Technology
7.19.1 Jiangsu Recbio Technology Details
7.19.2 Jiangsu Recbio Technology Major Business
7.19.3 Jiangsu Recbio Technology Intramuscular HPV Vaccine Product and Services
7.19.4 Jiangsu Recbio Technology Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Jiangsu Recbio Technology Recent Developments/Updates
7.19.6 Jiangsu Recbio Technology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Intramuscular HPV Vaccine Industry Chain
8.2 Intramuscular HPV Vaccine Upstream Analysis
8.2.1 Intramuscular HPV Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Intramuscular HPV Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Intramuscular HPV Vaccine Production Mode
8.6 Intramuscular HPV Vaccine Procurement Model
8.7 Intramuscular HPV Vaccine Industry Sales Model and Sales Channels
8.7.1 Intramuscular HPV Vaccine Sales Model
8.7.2 Intramuscular HPV Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Intramuscular HPV Vaccine Introduction
1.2 World Intramuscular HPV Vaccine Supply & Forecast
1.2.1 World Intramuscular HPV Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Intramuscular HPV Vaccine Production (2018-2029)
1.2.3 World Intramuscular HPV Vaccine Pricing Trends (2018-2029)
1.3 World Intramuscular HPV Vaccine Production by Region (Based on Production Site)
1.3.1 World Intramuscular HPV Vaccine Production Value by Region (2018-2029)
1.3.2 World Intramuscular HPV Vaccine Production by Region (2018-2029)
1.3.3 World Intramuscular HPV Vaccine Average Price by Region (2018-2029)
1.3.4 North America Intramuscular HPV Vaccine Production (2018-2029)
1.3.5 Europe Intramuscular HPV Vaccine Production (2018-2029)
1.3.6 China Intramuscular HPV Vaccine Production (2018-2029)
1.3.7 Japan Intramuscular HPV Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Intramuscular HPV Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Intramuscular HPV Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Intramuscular HPV Vaccine Demand (2018-2029)
2.2 World Intramuscular HPV Vaccine Consumption by Region
2.2.1 World Intramuscular HPV Vaccine Consumption by Region (2018-2023)
2.2.2 World Intramuscular HPV Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Intramuscular HPV Vaccine Consumption (2018-2029)
2.4 China Intramuscular HPV Vaccine Consumption (2018-2029)
2.5 Europe Intramuscular HPV Vaccine Consumption (2018-2029)
2.6 Japan Intramuscular HPV Vaccine Consumption (2018-2029)
2.7 South Korea Intramuscular HPV Vaccine Consumption (2018-2029)
2.8 ASEAN Intramuscular HPV Vaccine Consumption (2018-2029)
2.9 India Intramuscular HPV Vaccine Consumption (2018-2029)
3 WORLD INTRAMUSCULAR HPV VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Intramuscular HPV Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Intramuscular HPV Vaccine Production by Manufacturer (2018-2023)
3.3 World Intramuscular HPV Vaccine Average Price by Manufacturer (2018-2023)
3.4 Intramuscular HPV Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Intramuscular HPV Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Intramuscular HPV Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Intramuscular HPV Vaccine in 2022
3.6 Intramuscular HPV Vaccine Market: Overall Company Footprint Analysis
3.6.1 Intramuscular HPV Vaccine Market: Region Footprint
3.6.2 Intramuscular HPV Vaccine Market: Company Product Type Footprint
3.6.3 Intramuscular HPV Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Intramuscular HPV Vaccine Production Value Comparison
4.1.1 United States VS China: Intramuscular HPV Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Intramuscular HPV Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Intramuscular HPV Vaccine Production Comparison
4.2.1 United States VS China: Intramuscular HPV Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Intramuscular HPV Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Intramuscular HPV Vaccine Consumption Comparison
4.3.1 United States VS China: Intramuscular HPV Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Intramuscular HPV Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Intramuscular HPV Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Intramuscular HPV Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Intramuscular HPV Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Intramuscular HPV Vaccine Production (2018-2023)
4.5 China Based Intramuscular HPV Vaccine Manufacturers and Market Share
4.5.1 China Based Intramuscular HPV Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Intramuscular HPV Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Intramuscular HPV Vaccine Production (2018-2023)
4.6 Rest of World Based Intramuscular HPV Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Intramuscular HPV Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Intramuscular HPV Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Intramuscular HPV Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Intramuscular HPV Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Bivalent
5.2.2 Quadrivalent
5.2.3 Nine-valent
5.3 Market Segment by Type
5.3.1 World Intramuscular HPV Vaccine Production by Type (2018-2029)
5.3.2 World Intramuscular HPV Vaccine Production Value by Type (2018-2029)
5.3.3 World Intramuscular HPV Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Intramuscular HPV Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Male
6.2.2 Female
6.3 Market Segment by Application
6.3.1 World Intramuscular HPV Vaccine Production by Application (2018-2029)
6.3.2 World Intramuscular HPV Vaccine Production Value by Application (2018-2029)
6.3.3 World Intramuscular HPV Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck Sharp & Dohme (MSD)
7.1.1 Merck Sharp & Dohme (MSD) Details
7.1.2 Merck Sharp & Dohme (MSD) Major Business
7.1.3 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Product and Services
7.1.4 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Sharp & Dohme (MSD) Recent Developments/Updates
7.1.6 Merck Sharp & Dohme (MSD) Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Intramuscular HPV Vaccine Product and Services
7.2.4 Pfizer Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Sanofi
7.3.1 Sanofi Details
7.3.2 Sanofi Major Business
7.3.3 Sanofi Intramuscular HPV Vaccine Product and Services
7.3.4 Sanofi Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Sanofi Recent Developments/Updates
7.3.6 Sanofi Competitive Strengths & Weaknesses
7.4 GSK
7.4.1 GSK Details
7.4.2 GSK Major Business
7.4.3 GSK Intramuscular HPV Vaccine Product and Services
7.4.4 GSK Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 GSK Recent Developments/Updates
7.4.6 GSK Competitive Strengths & Weaknesses
7.5 Serum Institute
7.5.1 Serum Institute Details
7.5.2 Serum Institute Major Business
7.5.3 Serum Institute Intramuscular HPV Vaccine Product and Services
7.5.4 Serum Institute Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Serum Institute Recent Developments/Updates
7.5.6 Serum Institute Competitive Strengths & Weaknesses
7.6 Astellas Pharma
7.6.1 Astellas Pharma Details
7.6.2 Astellas Pharma Major Business
7.6.3 Astellas Pharma Intramuscular HPV Vaccine Product and Services
7.6.4 Astellas Pharma Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Astellas Pharma Recent Developments/Updates
7.6.6 Astellas Pharma Competitive Strengths & Weaknesses
7.7 CSL
7.7.1 CSL Details
7.7.2 CSL Major Business
7.7.3 CSL Intramuscular HPV Vaccine Product and Services
7.7.4 CSL Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 CSL Recent Developments/Updates
7.7.6 CSL Competitive Strengths & Weaknesses
7.8 Emergent BioSolutions
7.8.1 Emergent BioSolutions Details
7.8.2 Emergent BioSolutions Major Business
7.8.3 Emergent BioSolutions Intramuscular HPV Vaccine Product and Services
7.8.4 Emergent BioSolutions Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Emergent BioSolutions Recent Developments/Updates
7.8.6 Emergent BioSolutions Competitive Strengths & Weaknesses
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Details
7.9.2 GlaxoSmithKline Major Business
7.9.3 GlaxoSmithKline Intramuscular HPV Vaccine Product and Services
7.9.4 GlaxoSmithKline Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 GlaxoSmithKline Recent Developments/Updates
7.9.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Details
7.10.2 Johnson & Johnson Major Business
7.10.3 Johnson & Johnson Intramuscular HPV Vaccine Product and Services
7.10.4 Johnson & Johnson Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Johnson & Johnson Recent Developments/Updates
7.10.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.11 MedImmune
7.11.1 MedImmune Details
7.11.2 MedImmune Major Business
7.11.3 MedImmune Intramuscular HPV Vaccine Product and Services
7.11.4 MedImmune Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 MedImmune Recent Developments/Updates
7.11.6 MedImmune Competitive Strengths & Weaknesses
7.12 Walvax Biotechnology
7.12.1 Walvax Biotechnology Details
7.12.2 Walvax Biotechnology Major Business
7.12.3 Walvax Biotechnology Intramuscular HPV Vaccine Product and Services
7.12.4 Walvax Biotechnology Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Walvax Biotechnology Recent Developments/Updates
7.12.6 Walvax Biotechnology Competitive Strengths & Weaknesses
7.13 Liaoning Chengda Biotechnology
7.13.1 Liaoning Chengda Biotechnology Details
7.13.2 Liaoning Chengda Biotechnology Major Business
7.13.3 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Product and Services
7.13.4 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Liaoning Chengda Biotechnology Recent Developments/Updates
7.13.6 Liaoning Chengda Biotechnology Competitive Strengths & Weaknesses
7.14 Hualan Biological Engineering
7.14.1 Hualan Biological Engineering Details
7.14.2 Hualan Biological Engineering Major Business
7.14.3 Hualan Biological Engineering Intramuscular HPV Vaccine Product and Services
7.14.4 Hualan Biological Engineering Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Hualan Biological Engineering Recent Developments/Updates
7.14.6 Hualan Biological Engineering Competitive Strengths & Weaknesses
7.15 Sinovac Biotech
7.15.1 Sinovac Biotech Details
7.15.2 Sinovac Biotech Major Business
7.15.3 Sinovac Biotech Intramuscular HPV Vaccine Product and Services
7.15.4 Sinovac Biotech Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Sinovac Biotech Recent Developments/Updates
7.15.6 Sinovac Biotech Competitive Strengths & Weaknesses
7.16 Chongqing Zhifei Biological Products
7.16.1 Chongqing Zhifei Biological Products Details
7.16.2 Chongqing Zhifei Biological Products Major Business
7.16.3 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Product and Services
7.16.4 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Chongqing Zhifei Biological Products Recent Developments/Updates
7.16.6 Chongqing Zhifei Biological Products Competitive Strengths & Weaknesses
7.17 Chang Chun High and New Technology Industries (Group)
7.17.1 Chang Chun High and New Technology Industries (Group) Details
7.17.2 Chang Chun High and New Technology Industries (Group) Major Business
7.17.3 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Product and Services
7.17.4 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Chang Chun High and New Technology Industries (Group) Recent Developments/Updates
7.17.6 Chang Chun High and New Technology Industries (Group) Competitive Strengths & Weaknesses
7.18 Beijing Wantai Biological Pharmacy Enterprise
7.18.1 Beijing Wantai Biological Pharmacy Enterprise Details
7.18.2 Beijing Wantai Biological Pharmacy Enterprise Major Business
7.18.3 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Product and Services
7.18.4 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
7.18.6 Beijing Wantai Biological Pharmacy Enterprise Competitive Strengths & Weaknesses
7.19 Jiangsu Recbio Technology
7.19.1 Jiangsu Recbio Technology Details
7.19.2 Jiangsu Recbio Technology Major Business
7.19.3 Jiangsu Recbio Technology Intramuscular HPV Vaccine Product and Services
7.19.4 Jiangsu Recbio Technology Intramuscular HPV Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Jiangsu Recbio Technology Recent Developments/Updates
7.19.6 Jiangsu Recbio Technology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Intramuscular HPV Vaccine Industry Chain
8.2 Intramuscular HPV Vaccine Upstream Analysis
8.2.1 Intramuscular HPV Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Intramuscular HPV Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Intramuscular HPV Vaccine Production Mode
8.6 Intramuscular HPV Vaccine Procurement Model
8.7 Intramuscular HPV Vaccine Industry Sales Model and Sales Channels
8.7.1 Intramuscular HPV Vaccine Sales Model
8.7.2 Intramuscular HPV Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Intramuscular HPV Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Intramuscular HPV Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Intramuscular HPV Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Intramuscular HPV Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Intramuscular HPV Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Intramuscular HPV Vaccine Production by Region (2018-2023) & (Units)
Table 7. World Intramuscular HPV Vaccine Production by Region (2024-2029) & (Units)
Table 8. World Intramuscular HPV Vaccine Production Market Share by Region (2018-2023)
Table 9. World Intramuscular HPV Vaccine Production Market Share by Region (2024-2029)
Table 10. World Intramuscular HPV Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Intramuscular HPV Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Intramuscular HPV Vaccine Major Market Trends
Table 13. World Intramuscular HPV Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Units)
Table 14. World Intramuscular HPV Vaccine Consumption by Region (2018-2023) & (Units)
Table 15. World Intramuscular HPV Vaccine Consumption Forecast by Region (2024-2029) & (Units)
Table 16. World Intramuscular HPV Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Intramuscular HPV Vaccine Producers in 2022
Table 18. World Intramuscular HPV Vaccine Production by Manufacturer (2018-2023) & (Units)
Table 19. Production Market Share of Key Intramuscular HPV Vaccine Producers in 2022
Table 20. World Intramuscular HPV Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Intramuscular HPV Vaccine Company Evaluation Quadrant
Table 22. World Intramuscular HPV Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Intramuscular HPV Vaccine Production Site of Key Manufacturer
Table 24. Intramuscular HPV Vaccine Market: Company Product Type Footprint
Table 25. Intramuscular HPV Vaccine Market: Company Product Application Footprint
Table 26. Intramuscular HPV Vaccine Competitive Factors
Table 27. Intramuscular HPV Vaccine New Entrant and Capacity Expansion Plans
Table 28. Intramuscular HPV Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Intramuscular HPV Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Intramuscular HPV Vaccine Production Comparison, (2018 & 2022 & 2029) & (Units)
Table 31. United States VS China Intramuscular HPV Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (Units)
Table 32. United States Based Intramuscular HPV Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Intramuscular HPV Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Intramuscular HPV Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Intramuscular HPV Vaccine Production (2018-2023) & (Units)
Table 36. United States Based Manufacturers Intramuscular HPV Vaccine Production Market Share (2018-2023)
Table 37. China Based Intramuscular HPV Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Intramuscular HPV Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Intramuscular HPV Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Intramuscular HPV Vaccine Production (2018-2023) & (Units)
Table 41. China Based Manufacturers Intramuscular HPV Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Intramuscular HPV Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Intramuscular HPV Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Intramuscular HPV Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Intramuscular HPV Vaccine Production (2018-2023) & (Units)
Table 46. Rest of World Based Manufacturers Intramuscular HPV Vaccine Production Market Share (2018-2023)
Table 47. World Intramuscular HPV Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Intramuscular HPV Vaccine Production by Type (2018-2023) & (Units)
Table 49. World Intramuscular HPV Vaccine Production by Type (2024-2029) & (Units)
Table 50. World Intramuscular HPV Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Intramuscular HPV Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Intramuscular HPV Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Intramuscular HPV Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Intramuscular HPV Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Intramuscular HPV Vaccine Production by Application (2018-2023) & (Units)
Table 56. World Intramuscular HPV Vaccine Production by Application (2024-2029) & (Units)
Table 57. World Intramuscular HPV Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Intramuscular HPV Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Intramuscular HPV Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Intramuscular HPV Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck Sharp & Dohme (MSD) Basic Information, Manufacturing Base and Competitors
Table 62. Merck Sharp & Dohme (MSD) Major Business
Table 63. Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Product and Services
Table 64. Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck Sharp & Dohme (MSD) Recent Developments/Updates
Table 66. Merck Sharp & Dohme (MSD) Competitive Strengths & Weaknesses
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer Intramuscular HPV Vaccine Product and Services
Table 70. Pfizer Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Pfizer Recent Developments/Updates
Table 72. Pfizer Competitive Strengths & Weaknesses
Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Major Business
Table 75. Sanofi Intramuscular HPV Vaccine Product and Services
Table 76. Sanofi Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Sanofi Recent Developments/Updates
Table 78. Sanofi Competitive Strengths & Weaknesses
Table 79. GSK Basic Information, Manufacturing Base and Competitors
Table 80. GSK Major Business
Table 81. GSK Intramuscular HPV Vaccine Product and Services
Table 82. GSK Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. GSK Recent Developments/Updates
Table 84. GSK Competitive Strengths & Weaknesses
Table 85. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 86. Serum Institute Major Business
Table 87. Serum Institute Intramuscular HPV Vaccine Product and Services
Table 88. Serum Institute Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Serum Institute Recent Developments/Updates
Table 90. Serum Institute Competitive Strengths & Weaknesses
Table 91. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Astellas Pharma Major Business
Table 93. Astellas Pharma Intramuscular HPV Vaccine Product and Services
Table 94. Astellas Pharma Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Astellas Pharma Recent Developments/Updates
Table 96. Astellas Pharma Competitive Strengths & Weaknesses
Table 97. CSL Basic Information, Manufacturing Base and Competitors
Table 98. CSL Major Business
Table 99. CSL Intramuscular HPV Vaccine Product and Services
Table 100. CSL Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. CSL Recent Developments/Updates
Table 102. CSL Competitive Strengths & Weaknesses
Table 103. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 104. Emergent BioSolutions Major Business
Table 105. Emergent BioSolutions Intramuscular HPV Vaccine Product and Services
Table 106. Emergent BioSolutions Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Emergent BioSolutions Recent Developments/Updates
Table 108. Emergent BioSolutions Competitive Strengths & Weaknesses
Table 109. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 110. GlaxoSmithKline Major Business
Table 111. GlaxoSmithKline Intramuscular HPV Vaccine Product and Services
Table 112. GlaxoSmithKline Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. GlaxoSmithKline Recent Developments/Updates
Table 114. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 115. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 116. Johnson & Johnson Major Business
Table 117. Johnson & Johnson Intramuscular HPV Vaccine Product and Services
Table 118. Johnson & Johnson Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Johnson & Johnson Recent Developments/Updates
Table 120. Johnson & Johnson Competitive Strengths & Weaknesses
Table 121. MedImmune Basic Information, Manufacturing Base and Competitors
Table 122. MedImmune Major Business
Table 123. MedImmune Intramuscular HPV Vaccine Product and Services
Table 124. MedImmune Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. MedImmune Recent Developments/Updates
Table 126. MedImmune Competitive Strengths & Weaknesses
Table 127. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 128. Walvax Biotechnology Major Business
Table 129. Walvax Biotechnology Intramuscular HPV Vaccine Product and Services
Table 130. Walvax Biotechnology Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Walvax Biotechnology Recent Developments/Updates
Table 132. Walvax Biotechnology Competitive Strengths & Weaknesses
Table 133. Liaoning Chengda Biotechnology Basic Information, Manufacturing Base and Competitors
Table 134. Liaoning Chengda Biotechnology Major Business
Table 135. Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Product and Services
Table 136. Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Liaoning Chengda Biotechnology Recent Developments/Updates
Table 138. Liaoning Chengda Biotechnology Competitive Strengths & Weaknesses
Table 139. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 140. Hualan Biological Engineering Major Business
Table 141. Hualan Biological Engineering Intramuscular HPV Vaccine Product and Services
Table 142. Hualan Biological Engineering Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Hualan Biological Engineering Recent Developments/Updates
Table 144. Hualan Biological Engineering Competitive Strengths & Weaknesses
Table 145. Sinovac Biotech Basic Information, Manufacturing Base and Competitors
Table 146. Sinovac Biotech Major Business
Table 147. Sinovac Biotech Intramuscular HPV Vaccine Product and Services
Table 148. Sinovac Biotech Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Sinovac Biotech Recent Developments/Updates
Table 150. Sinovac Biotech Competitive Strengths & Weaknesses
Table 151. Chongqing Zhifei Biological Products Basic Information, Manufacturing Base and Competitors
Table 152. Chongqing Zhifei Biological Products Major Business
Table 153. Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Product and Services
Table 154. Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Chongqing Zhifei Biological Products Recent Developments/Updates
Table 156. Chongqing Zhifei Biological Products Competitive Strengths & Weaknesses
Table 157. Chang Chun High and New Technology Industries (Group) Basic Information, Manufacturing Base and Competitors
Table 158. Chang Chun High and New Technology Industries (Group) Major Business
Table 159. Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Product and Services
Table 160. Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Chang Chun High and New Technology Industries (Group) Recent Developments/Updates
Table 162. Chang Chun High and New Technology Industries (Group) Competitive Strengths & Weaknesses
Table 163. Beijing Wantai Biological Pharmacy Enterprise Basic Information, Manufacturing Base and Competitors
Table 164. Beijing Wantai Biological Pharmacy Enterprise Major Business
Table 165. Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Product and Services
Table 166. Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
Table 168. Jiangsu Recbio Technology Basic Information, Manufacturing Base and Competitors
Table 169. Jiangsu Recbio Technology Major Business
Table 170. Jiangsu Recbio Technology Intramuscular HPV Vaccine Product and Services
Table 171. Jiangsu Recbio Technology Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 172. Global Key Players of Intramuscular HPV Vaccine Upstream (Raw Materials)
Table 173. Intramuscular HPV Vaccine Typical Customers
Table 174. Intramuscular HPV Vaccine Typical Distributors
Table 1. World Intramuscular HPV Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Intramuscular HPV Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Intramuscular HPV Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Intramuscular HPV Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Intramuscular HPV Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Intramuscular HPV Vaccine Production by Region (2018-2023) & (Units)
Table 7. World Intramuscular HPV Vaccine Production by Region (2024-2029) & (Units)
Table 8. World Intramuscular HPV Vaccine Production Market Share by Region (2018-2023)
Table 9. World Intramuscular HPV Vaccine Production Market Share by Region (2024-2029)
Table 10. World Intramuscular HPV Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Intramuscular HPV Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Intramuscular HPV Vaccine Major Market Trends
Table 13. World Intramuscular HPV Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (Units)
Table 14. World Intramuscular HPV Vaccine Consumption by Region (2018-2023) & (Units)
Table 15. World Intramuscular HPV Vaccine Consumption Forecast by Region (2024-2029) & (Units)
Table 16. World Intramuscular HPV Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Intramuscular HPV Vaccine Producers in 2022
Table 18. World Intramuscular HPV Vaccine Production by Manufacturer (2018-2023) & (Units)
Table 19. Production Market Share of Key Intramuscular HPV Vaccine Producers in 2022
Table 20. World Intramuscular HPV Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Intramuscular HPV Vaccine Company Evaluation Quadrant
Table 22. World Intramuscular HPV Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Intramuscular HPV Vaccine Production Site of Key Manufacturer
Table 24. Intramuscular HPV Vaccine Market: Company Product Type Footprint
Table 25. Intramuscular HPV Vaccine Market: Company Product Application Footprint
Table 26. Intramuscular HPV Vaccine Competitive Factors
Table 27. Intramuscular HPV Vaccine New Entrant and Capacity Expansion Plans
Table 28. Intramuscular HPV Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Intramuscular HPV Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Intramuscular HPV Vaccine Production Comparison, (2018 & 2022 & 2029) & (Units)
Table 31. United States VS China Intramuscular HPV Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (Units)
Table 32. United States Based Intramuscular HPV Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Intramuscular HPV Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Intramuscular HPV Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Intramuscular HPV Vaccine Production (2018-2023) & (Units)
Table 36. United States Based Manufacturers Intramuscular HPV Vaccine Production Market Share (2018-2023)
Table 37. China Based Intramuscular HPV Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Intramuscular HPV Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Intramuscular HPV Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Intramuscular HPV Vaccine Production (2018-2023) & (Units)
Table 41. China Based Manufacturers Intramuscular HPV Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Intramuscular HPV Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Intramuscular HPV Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Intramuscular HPV Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Intramuscular HPV Vaccine Production (2018-2023) & (Units)
Table 46. Rest of World Based Manufacturers Intramuscular HPV Vaccine Production Market Share (2018-2023)
Table 47. World Intramuscular HPV Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Intramuscular HPV Vaccine Production by Type (2018-2023) & (Units)
Table 49. World Intramuscular HPV Vaccine Production by Type (2024-2029) & (Units)
Table 50. World Intramuscular HPV Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Intramuscular HPV Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Intramuscular HPV Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Intramuscular HPV Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Intramuscular HPV Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Intramuscular HPV Vaccine Production by Application (2018-2023) & (Units)
Table 56. World Intramuscular HPV Vaccine Production by Application (2024-2029) & (Units)
Table 57. World Intramuscular HPV Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Intramuscular HPV Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Intramuscular HPV Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Intramuscular HPV Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck Sharp & Dohme (MSD) Basic Information, Manufacturing Base and Competitors
Table 62. Merck Sharp & Dohme (MSD) Major Business
Table 63. Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Product and Services
Table 64. Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck Sharp & Dohme (MSD) Recent Developments/Updates
Table 66. Merck Sharp & Dohme (MSD) Competitive Strengths & Weaknesses
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer Intramuscular HPV Vaccine Product and Services
Table 70. Pfizer Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Pfizer Recent Developments/Updates
Table 72. Pfizer Competitive Strengths & Weaknesses
Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Major Business
Table 75. Sanofi Intramuscular HPV Vaccine Product and Services
Table 76. Sanofi Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Sanofi Recent Developments/Updates
Table 78. Sanofi Competitive Strengths & Weaknesses
Table 79. GSK Basic Information, Manufacturing Base and Competitors
Table 80. GSK Major Business
Table 81. GSK Intramuscular HPV Vaccine Product and Services
Table 82. GSK Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. GSK Recent Developments/Updates
Table 84. GSK Competitive Strengths & Weaknesses
Table 85. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 86. Serum Institute Major Business
Table 87. Serum Institute Intramuscular HPV Vaccine Product and Services
Table 88. Serum Institute Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Serum Institute Recent Developments/Updates
Table 90. Serum Institute Competitive Strengths & Weaknesses
Table 91. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Astellas Pharma Major Business
Table 93. Astellas Pharma Intramuscular HPV Vaccine Product and Services
Table 94. Astellas Pharma Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Astellas Pharma Recent Developments/Updates
Table 96. Astellas Pharma Competitive Strengths & Weaknesses
Table 97. CSL Basic Information, Manufacturing Base and Competitors
Table 98. CSL Major Business
Table 99. CSL Intramuscular HPV Vaccine Product and Services
Table 100. CSL Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. CSL Recent Developments/Updates
Table 102. CSL Competitive Strengths & Weaknesses
Table 103. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 104. Emergent BioSolutions Major Business
Table 105. Emergent BioSolutions Intramuscular HPV Vaccine Product and Services
Table 106. Emergent BioSolutions Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Emergent BioSolutions Recent Developments/Updates
Table 108. Emergent BioSolutions Competitive Strengths & Weaknesses
Table 109. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 110. GlaxoSmithKline Major Business
Table 111. GlaxoSmithKline Intramuscular HPV Vaccine Product and Services
Table 112. GlaxoSmithKline Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. GlaxoSmithKline Recent Developments/Updates
Table 114. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 115. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 116. Johnson & Johnson Major Business
Table 117. Johnson & Johnson Intramuscular HPV Vaccine Product and Services
Table 118. Johnson & Johnson Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Johnson & Johnson Recent Developments/Updates
Table 120. Johnson & Johnson Competitive Strengths & Weaknesses
Table 121. MedImmune Basic Information, Manufacturing Base and Competitors
Table 122. MedImmune Major Business
Table 123. MedImmune Intramuscular HPV Vaccine Product and Services
Table 124. MedImmune Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. MedImmune Recent Developments/Updates
Table 126. MedImmune Competitive Strengths & Weaknesses
Table 127. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 128. Walvax Biotechnology Major Business
Table 129. Walvax Biotechnology Intramuscular HPV Vaccine Product and Services
Table 130. Walvax Biotechnology Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Walvax Biotechnology Recent Developments/Updates
Table 132. Walvax Biotechnology Competitive Strengths & Weaknesses
Table 133. Liaoning Chengda Biotechnology Basic Information, Manufacturing Base and Competitors
Table 134. Liaoning Chengda Biotechnology Major Business
Table 135. Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Product and Services
Table 136. Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Liaoning Chengda Biotechnology Recent Developments/Updates
Table 138. Liaoning Chengda Biotechnology Competitive Strengths & Weaknesses
Table 139. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 140. Hualan Biological Engineering Major Business
Table 141. Hualan Biological Engineering Intramuscular HPV Vaccine Product and Services
Table 142. Hualan Biological Engineering Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Hualan Biological Engineering Recent Developments/Updates
Table 144. Hualan Biological Engineering Competitive Strengths & Weaknesses
Table 145. Sinovac Biotech Basic Information, Manufacturing Base and Competitors
Table 146. Sinovac Biotech Major Business
Table 147. Sinovac Biotech Intramuscular HPV Vaccine Product and Services
Table 148. Sinovac Biotech Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Sinovac Biotech Recent Developments/Updates
Table 150. Sinovac Biotech Competitive Strengths & Weaknesses
Table 151. Chongqing Zhifei Biological Products Basic Information, Manufacturing Base and Competitors
Table 152. Chongqing Zhifei Biological Products Major Business
Table 153. Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Product and Services
Table 154. Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Chongqing Zhifei Biological Products Recent Developments/Updates
Table 156. Chongqing Zhifei Biological Products Competitive Strengths & Weaknesses
Table 157. Chang Chun High and New Technology Industries (Group) Basic Information, Manufacturing Base and Competitors
Table 158. Chang Chun High and New Technology Industries (Group) Major Business
Table 159. Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Product and Services
Table 160. Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Chang Chun High and New Technology Industries (Group) Recent Developments/Updates
Table 162. Chang Chun High and New Technology Industries (Group) Competitive Strengths & Weaknesses
Table 163. Beijing Wantai Biological Pharmacy Enterprise Basic Information, Manufacturing Base and Competitors
Table 164. Beijing Wantai Biological Pharmacy Enterprise Major Business
Table 165. Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Product and Services
Table 166. Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
Table 168. Jiangsu Recbio Technology Basic Information, Manufacturing Base and Competitors
Table 169. Jiangsu Recbio Technology Major Business
Table 170. Jiangsu Recbio Technology Intramuscular HPV Vaccine Product and Services
Table 171. Jiangsu Recbio Technology Intramuscular HPV Vaccine Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 172. Global Key Players of Intramuscular HPV Vaccine Upstream (Raw Materials)
Table 173. Intramuscular HPV Vaccine Typical Customers
Table 174. Intramuscular HPV Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Intramuscular HPV Vaccine Picture
Figure 2. World Intramuscular HPV Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Intramuscular HPV Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Intramuscular HPV Vaccine Production (2018-2029) & (Units)
Figure 5. World Intramuscular HPV Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Intramuscular HPV Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Intramuscular HPV Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Intramuscular HPV Vaccine Production (2018-2029) & (Units)
Figure 9. Europe Intramuscular HPV Vaccine Production (2018-2029) & (Units)
Figure 10. China Intramuscular HPV Vaccine Production (2018-2029) & (Units)
Figure 11. Japan Intramuscular HPV Vaccine Production (2018-2029) & (Units)
Figure 12. Intramuscular HPV Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Intramuscular HPV Vaccine Consumption (2018-2029) & (Units)
Figure 15. World Intramuscular HPV Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Intramuscular HPV Vaccine Consumption (2018-2029) & (Units)
Figure 17. China Intramuscular HPV Vaccine Consumption (2018-2029) & (Units)
Figure 18. Europe Intramuscular HPV Vaccine Consumption (2018-2029) & (Units)
Figure 19. Japan Intramuscular HPV Vaccine Consumption (2018-2029) & (Units)
Figure 20. South Korea Intramuscular HPV Vaccine Consumption (2018-2029) & (Units)
Figure 21. ASEAN Intramuscular HPV Vaccine Consumption (2018-2029) & (Units)
Figure 22. India Intramuscular HPV Vaccine Consumption (2018-2029) & (Units)
Figure 23. Producer Shipments of Intramuscular HPV Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Intramuscular HPV Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Intramuscular HPV Vaccine Markets in 2022
Figure 26. United States VS China: Intramuscular HPV Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Intramuscular HPV Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Intramuscular HPV Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Intramuscular HPV Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Intramuscular HPV Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Intramuscular HPV Vaccine Production Market Share 2022
Figure 32. World Intramuscular HPV Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Intramuscular HPV Vaccine Production Value Market Share by Type in 2022
Figure 34. Bivalent
Figure 35. Quadrivalent
Figure 36. Nine-valent
Figure 37. World Intramuscular HPV Vaccine Production Market Share by Type (2018-2029)
Figure 38. World Intramuscular HPV Vaccine Production Value Market Share by Type (2018-2029)
Figure 39. World Intramuscular HPV Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Intramuscular HPV Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Intramuscular HPV Vaccine Production Value Market Share by Application in 2022
Figure 42. Male
Figure 43. Female
Figure 44. World Intramuscular HPV Vaccine Production Market Share by Application (2018-2029)
Figure 45. World Intramuscular HPV Vaccine Production Value Market Share by Application (2018-2029)
Figure 46. World Intramuscular HPV Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Intramuscular HPV Vaccine Industry Chain
Figure 48. Intramuscular HPV Vaccine Procurement Model
Figure 49. Intramuscular HPV Vaccine Sales Model
Figure 50. Intramuscular HPV Vaccine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Intramuscular HPV Vaccine Picture
Figure 2. World Intramuscular HPV Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Intramuscular HPV Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Intramuscular HPV Vaccine Production (2018-2029) & (Units)
Figure 5. World Intramuscular HPV Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Intramuscular HPV Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Intramuscular HPV Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Intramuscular HPV Vaccine Production (2018-2029) & (Units)
Figure 9. Europe Intramuscular HPV Vaccine Production (2018-2029) & (Units)
Figure 10. China Intramuscular HPV Vaccine Production (2018-2029) & (Units)
Figure 11. Japan Intramuscular HPV Vaccine Production (2018-2029) & (Units)
Figure 12. Intramuscular HPV Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Intramuscular HPV Vaccine Consumption (2018-2029) & (Units)
Figure 15. World Intramuscular HPV Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Intramuscular HPV Vaccine Consumption (2018-2029) & (Units)
Figure 17. China Intramuscular HPV Vaccine Consumption (2018-2029) & (Units)
Figure 18. Europe Intramuscular HPV Vaccine Consumption (2018-2029) & (Units)
Figure 19. Japan Intramuscular HPV Vaccine Consumption (2018-2029) & (Units)
Figure 20. South Korea Intramuscular HPV Vaccine Consumption (2018-2029) & (Units)
Figure 21. ASEAN Intramuscular HPV Vaccine Consumption (2018-2029) & (Units)
Figure 22. India Intramuscular HPV Vaccine Consumption (2018-2029) & (Units)
Figure 23. Producer Shipments of Intramuscular HPV Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Intramuscular HPV Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Intramuscular HPV Vaccine Markets in 2022
Figure 26. United States VS China: Intramuscular HPV Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Intramuscular HPV Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Intramuscular HPV Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Intramuscular HPV Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Intramuscular HPV Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Intramuscular HPV Vaccine Production Market Share 2022
Figure 32. World Intramuscular HPV Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Intramuscular HPV Vaccine Production Value Market Share by Type in 2022
Figure 34. Bivalent
Figure 35. Quadrivalent
Figure 36. Nine-valent
Figure 37. World Intramuscular HPV Vaccine Production Market Share by Type (2018-2029)
Figure 38. World Intramuscular HPV Vaccine Production Value Market Share by Type (2018-2029)
Figure 39. World Intramuscular HPV Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Intramuscular HPV Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Intramuscular HPV Vaccine Production Value Market Share by Application in 2022
Figure 42. Male
Figure 43. Female
Figure 44. World Intramuscular HPV Vaccine Production Market Share by Application (2018-2029)
Figure 45. World Intramuscular HPV Vaccine Production Value Market Share by Application (2018-2029)
Figure 46. World Intramuscular HPV Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Intramuscular HPV Vaccine Industry Chain
Figure 48. Intramuscular HPV Vaccine Procurement Model
Figure 49. Intramuscular HPV Vaccine Sales Model
Figure 50. Intramuscular HPV Vaccine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
